BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11520582)

  • 1. Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
    Bazarbachi A; Hermine O
    Virus Res; 2001 Oct; 78(1-2):79-92. PubMed ID: 11520582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of Targeted Therapies for Adult T-Cell Leukemia/Lymphoma.
    Nasr R; Marçais A; Hermine O; Bazarbachi A
    Methods Mol Biol; 2017; 1582():197-216. PubMed ID: 28357672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha.
    Mahieux R; Hermine O
    Leuk Lymphoma; 2005 Mar; 46(3):347-55. PubMed ID: 15621824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How I treat adult T-cell leukemia/lymphoma.
    Bazarbachi A; Suarez F; Fields P; Hermine O
    Blood; 2011 Aug; 118(7):1736-45. PubMed ID: 21673346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
    Kchour G; Tarhini M; Kooshyar MM; El Hajj H; Wattel E; Mahmoudi M; Hatoum H; Rahimi H; Maleki M; Rafatpanah H; Rezaee SA; Yazdi MT; Shirdel A; de Thé H; Hermine O; Farid R; Bazarbachi A
    Blood; 2009 Jun; 113(26):6528-32. PubMed ID: 19411628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?
    Nasr R; El Hajj H; Kfoury Y; de Thé H; Hermine O; Bazarbachi A
    Viruses; 2011 Jun; 3(6):750-69. PubMed ID: 21994752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients.
    Bazarbachi A; Hermine O
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S186-90. PubMed ID: 8797722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
    Hermine O; Dombret H; Poupon J; Arnulf B; Lefrère F; Rousselot P; Damaj G; Delarue R; Fermand JP; Brouet JC; Degos L; Varet B; de Thé H; Bazarbachi A
    Hematol J; 2004; 5(2):130-4. PubMed ID: 15048063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult T-cell leukemia/lymphoma and HTLV-1.
    Mahieux R; Gessain A
    Curr Hematol Malig Rep; 2007 Oct; 2(4):257-64. PubMed ID: 20425378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells.
    Nasr R; Rosenwald A; El-Sabban ME; Arnulf B; Zalloua P; Lepelletier Y; Bex F; Hermine O; Staudt L; de Thé H; Bazarbachi A
    Blood; 2003 Jun; 101(11):4576-82. PubMed ID: 12560223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
    Kchour G; Rezaee R; Farid R; Ghantous A; Rafatpanah H; Tarhini M; Kooshyar MM; El Hajj H; Berry F; Mortada M; Nasser R; Shirdel A; Dassouki Z; Ezzedine M; Rahimi H; Ghavamzadeh A; de Thé H; Hermine O; Mahmoudi M; Bazarbachi A
    Retrovirology; 2013 Aug; 10():91. PubMed ID: 23962110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the treatment of adult T-cell leukemia-lymphomas.
    Utsunomiya A; Choi I; Chihara D; Seto M
    Cancer Sci; 2015 Apr; 106(4):344-51. PubMed ID: 25613789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.
    Kchour G; Makhoul NJ; Mahmoudi M; Kooshyar MM; Shirdel A; Rastin M; Rafatpanah H; Tarhini M; Zalloua PA; Hermine O; Farid R; Bazarbachi A
    Leuk Lymphoma; 2007 Feb; 48(2):330-6. PubMed ID: 17325893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I-transformed cells.
    Darwiche N; El-Sabban M; Bazzi R; Nasr R; Al-Hashimi S; Hermine O; de Thé H; Bazarbachi A
    Hematol J; 2001; 2(2):127-35. PubMed ID: 11424005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapeutic approaches for adult T-cell leukaemia.
    Bazarbachi A; Ghez D; Lepelletier Y; Nasr R; de Thé H; El-Sabban ME; Hermine O
    Lancet Oncol; 2004 Nov; 5(11):664-72. PubMed ID: 15522654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma.
    Bazarbachi A; Nasr R; El-Sabban ME; Mahé A; Mahieux R; Gessain A; Darwiche N; Dbaibo G; Kersual J; Zermati Y; Dianoux L; Chelbi-Alix MK; de Thé H; Hermine O
    Leukemia; 2000 Apr; 14(4):716-21. PubMed ID: 10764160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide (As
    Marçais A; Cook L; Witkover A; Asnafi V; Avettand-Fenoel V; Delarue R; Cheminant M; Sibon D; Frenzel L; de Thé H; Bangham CRM; Bazarbachi A; Hermine O; Suarez F
    Retrovirology; 2020 Mar; 17(1):5. PubMed ID: 32199462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus).
    Heraud JM; Mortreux F; Merien F; Contamin H; Mahieux R; Pouliquen JF; Wattel E; Gessain A; de Thé H; Bazarbachi A; Hermine O; Kazanji M
    Antiviral Res; 2006 Jul; 70(3):132-9. PubMed ID: 16540180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.
    Bazarbachi A; Plumelle Y; Carlos Ramos J; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; Panelatti G; Hermine O
    J Clin Oncol; 2010 Sep; 28(27):4177-83. PubMed ID: 20585095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adult T-cell leukemia/lymphoma. Therapeutic aspects].
    Besson C; Plumelle Y; Arnulf B; Gonin C; Panelatti G; Bazarbachi A; Hermine O
    Presse Med; 2001 Feb; 30(5):243-5. PubMed ID: 12385063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.